Day: November 6, 2022

Request Appointment >

ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022

November 6, 2022

The results come from analysis of the pooled data from ReCor’s RADIANCE Global Clinical Trial Program.

Twitter Youtube Linkedin

The PARADISE^® system is FDA approved for sale in the United States and is CE marked and approved for sale in markets where the CE mark is accepted.

RECOR MEDICAL, PARADISE, and the Swirl logo are registered trademarks of Recor Medical, Inc. in the United States and other countries. RADIANCE, the RADIANCE logo, RECOR, HYDROCOOLING, the GPS logo, and SONOWAVE 360 are also trademarks of Recor Medical, Inc.

Location Restriction

The content on this website is intended for United States residents only. Are you a United States resident?

This will close in 0 seconds

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Share on Facebook

Share on LinkedIn

Share on Twitter

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Our Blog

+ 1 541-754-3010

Day: November 6, 2022

+ 1 541-754-3010

ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022

Share